SCHEMBL6207558

SCHEMBL6207558

O=C(NCCCCl)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12.O=C(NCCCN1CCC1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12

nearest known ligand 0.58

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 14/20 0.58
CDK1 P06493 1/20 0.54
CDK2 P24941 1/20 0.54
CYP1A2 P05177 4/20 0.44
PKM P14618 1/20 0.44
HTR3A P46098 1/20 0.43
GSK3A P49840 1/20 0.43
ACHE P22303 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SMYD2 Q9NRG4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4500932 0.97 GSK3B (0.62) GSK3BCDK1CDK2CYP1A2PKM
SCHEMBL1461200 0.91 GSK3B (0.61) GSK3BCDK1CDK2CYP1A2PKM
SCHEMBL4492373 0.90 GSK3B (0.70) GSK3BCDK1CDK2CYP1A2
SCHEMBL4494753 0.89 GSK3B (0.64) GSK3BCDK1CDK2CYP1A2GSK3A
SCHEMBL6207556 0.84 GSK3B (0.46) GSK3BCDK1CDK2CYP1A2GSK3A
SCHEMBL4492707 0.82 GSK3B (0.69) GSK3BCDK1CDK2CYP1A2
SCHEMBL4497559 0.81 GSK3B (0.74) GSK3BCDK1CDK2CYP1A2
SCHEMBL4509800 0.80 GSK3B (0.59) GSK3BCDK1CDK2CYP1A2KDM4E
SCHEMBL4499482 0.80 GSK3B (0.75) GSK3BCDK1CDK2CYP1A2GSK3A
SCHEMBL27623027 0.79 GSK3B (0.70) GSK3BCDK1CDK2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537087-A1 NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 2005-06-08 EP disclosed
WO-2004022544-A1 NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2004-03-18 WO disclosed